Preeclampsia: Contemporary Concepts in Pathophysiology, Risk Stratification, Prevention and Monitoring
Open Access
- 4 March 2026
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (5) , 1944
Abstract
Preeclampsia is a heterogeneous disorder affecting approximately 2–5% of pregnancies and remains a major cause of maternal and perinatal morbidity and mortality worldwide. Its clinical presentation ranges from mild, nearly asymptomatic forms to severe conditions progressing to eclampsia or HELLP syndrome. Despite significant advances in understanding its pathophysiology, preeclampsia continues to pose diagnostic and therapeutic challenges. In recent years, intensive research efforts have focused on developing comprehensive diagnostic criteria, identifying novel biomarkers, improving risk prediction models, and establishing effective preventive and monitoring strategies. However, expert opinions and clinical guidelines remain partially inconsistent. This review aims to summarize current global concepts regarding the epidemiology, pathophysiology, risk stratification, diagnosis, prevention, and monitoring of preeclampsia, with particular emphasis on emerging biomarkers and personalized approaches to patient care.Keywords
This publication has 50 references indexed in Scilit:
- HIF-1α-mediated inhibition of the sFlt-1/sENG/TNF-α pathway promotes angiogenesis to ameliorate pre-eclampsiaJournal of Molecular Histology, 2025
- Aspirin Discontinuation at 24 to 28 Weeks’ Gestation in Pregnancies at High Risk of Preterm PreeclampsiaJAMA, 2023
- Prevention of preeclampsia with aspirinAmerican Journal of Obstetrics and Gynecology, 2022
- First trimester preeclampsia screening and predictionAmerican Journal of Obstetrics and Gynecology, 2022
- Multiple Gestations and Hypertensive Disorders of Pregnancy: What Do We Know?Current Hypertension Reports, 2020
- Screening for pre‐eclampsia at 11–13 weeks' gestation: use of pregnancy‐associated plasma protein‐A, placental growth factor or bothUltrasound in Obstetrics & Gynecology, 2020
- Vitexin ameliorates preeclampsia phenotypes by inhibiting TFPI‐2 and HIF‐1α/VEGF in a l‐NAME induced rat modelDrug Development Research, 2019
- The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre‐eclampsia: A pragmatic guide for first‐trimester screening and preventionInternational Journal of Gynecology & Obstetrics, 2019
- Screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestationUltrasound in Obstetrics & Gynecology, 2018
- Implementation of the sFlt‐1/PlGF ratio for prediction and diagnosis of pre‐eclampsia in singleton pregnancy: implications for clinical practiceUltrasound in Obstetrics & Gynecology, 2015